Literature DB >> 17097366

Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.

Pierre Wolkenstein1, Anderson Loundou, Karine Barrau, Pascal Auquier, Jean Revuz.   

Abstract

OBJECTIVE: We sought to determine quality of life impairment in hidradenitis suppurativa.
METHODS: Questionnaires were administered to 61 patients.
RESULTS: Quality of life impact in hidradenitis was much greater than that of several other dermatologic conditions. LIMITATION: This hospital-based population may not be representative.
CONCLUSION: Hidradenitis is one of the most distressing conditions observed in dermatology.

Entities:  

Mesh:

Year:  2006        PMID: 17097366     DOI: 10.1016/j.jaad.2006.08.061

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  42 in total

1.  Severity and Area Score for Hidradenitis (SASH): a novel outcome measurement for hidradenitis suppurativa.

Authors:  J S Kirby; M Butt; T King
Journal:  Br J Dermatol       Date:  2019-08-27       Impact factor: 9.302

2.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

Review 3.  [Hidradenitis suppurativa/acne inversa: An update].

Authors:  J Kirschke; S Hessam; F G Bechara
Journal:  Hautarzt       Date:  2015-06       Impact factor: 0.751

4.  The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials.

Authors:  J S Kirby; L Thorlacius; B Villumsen; J R Ingram; A Garg; K B Christensen; M Butt; S Esmann; J Tan; G B E Jemec
Journal:  Br J Dermatol       Date:  2019-12-26       Impact factor: 9.302

5.  Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota.

Authors:  Benjamin G Vazquez; Ali Alikhan; Amy L Weaver; David A Wetter; Mark D Davis
Journal:  J Invest Dermatol       Date:  2012-08-30       Impact factor: 8.551

Review 6.  [Acne inversa/hidradenitis suppurativa: An update].

Authors:  R Sabat; A Tsaousi; J Rossbacher; H Kurzen; T Fadai; U Schwichtenberg; S Schneider-Burrus; G Kokolakis; K Wolk
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

Review 7.  Hidradenitis suppurativa in children and adolescents: a review of treatment options.

Authors:  Peter Riis Mikkelsen; Gregor B E Jemec
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

8.  A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.

Authors:  Robert A Lee; Erica Dommasch; James Treat; Joslyn Sciacca-Kirby; Samuel Chachkin; Jennifer Williams; Daniel B Shin; James J Leyden; Carmela Vittorio; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2009-01-31       Impact factor: 11.527

Review 9.  [Acne inversa/hidradenitis suppurativa: A challenge for the future].

Authors:  R Sabat
Journal:  Hautarzt       Date:  2017-12       Impact factor: 0.751

10.  Association of Resilience With Depression and Health-Related Quality of Life for Patients With Hidradenitis Suppurativa.

Authors:  Joslyn S Kirby; Melissa Butt; Solveig Esmann; Gregor B E Jemec
Journal:  JAMA Dermatol       Date:  2017-12-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.